Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-25

Clinical Trial Update: Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease [NA]

View source ↗

Summary

A completed clinical trial evaluated a probiotic supplement versus placebo for non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic supplement

Snippet

Sponsor: Phramongkutklao College of Medicine and Hospital | Conditions: Fatty Liver, Nonalcoholic | NA | Status: COMPLETED